Establishment Labs Holdings Inc.,a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced the appointment of Raj Denhoy as Chief Financial Officer effective immediately. Mr. Denhoy has been with the company since 2021, including as Interim Chief Financial Officer since August.
Latest Fintech Insights: EasyCash: An Interoperable ePayment Suite Powered By Wallet Factory Launched In Egypt
“Raj has quickly become a trusted and vital colleague to me and many others at Establishment Labs”
“Raj has quickly become a trusted and vital colleague to me and many others at Establishment Labs,” said Juan José Chacón-Quirós, Founder and CEO of Establishment Labs. “His depth of knowledge about our business and industry are matched by a clear vision of what we must do to achieve success as a global leader in women’s health. After discussions with a number of qualified candidates during this process, I could not be more pleased that Raj has accepted the position of our Chief Financial Officer.”
“I am grateful every day to be part of the exceptional team at Establishment Labs,” said Raj Denhoy. “What we have accomplished already is significant, but the next chapter in our story will be even more consequential. It is within our reach to become not only the leading global company in breast aesthetics and reconstruction, but to fundamentally transform and expand these markets through science and consumer-centric innovation. It is a privilege to be taking on this expanded role as we work to create value for all our stakeholders.”
Browse The Complete News About Fintech : Bristol Myers Squibb Announces Dividend Increase and Additional $15 Billion Share Repurchase Authorization
Raj Denhoy joined Establishment Labs in February 2021 as the company’s Head of Strategy and Investor Relations and has served as Interim Chief Financial Officer since August 2021. Prior to joining the company, he was with Jefferies Group, LLC where he was a Managing Director and led the US medical device research team for the previous eleven years, including coverage of Establishment Labs. He covered the medical device industry as an equity research analyst for over twenty years. Mr. Denhoy holds a bachelor’s degree in biology from UC Berkeley, a master’s degree in physiology from Georgetown University, and an MBA from Cornell University.
Read More About Fintech News : Northisle Announces $1.9 Million Strategic Investment By Michael Gentile, CFA And Pierre Beaudoin
[To share your insights with us, please write to sghosh@martechseries.com]
